Citadel Advisors
INBS icon

Citadel Advisors’s Intelligent Bio Solutions INBS Stock Holding History

Citadel Advisors’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,484
Closed -$62.6K – 14816
2024
Q1 		$62.6K Buy
1,484
+181
+14% +$7.49K ﹤0.01% 11948
2023
Q4 		$52.7K Buy
+1,303
New +$51.2K ﹤0.01% 11730
2023
Q1 		– Sell
-29
Closed -$13.9K – 15073
2022
Q4 		$13.9K Buy
29
+15
+107% +$14.4K ﹤0.01% 13416
2022
Q3 		$15K Buy
+14
New +$21.2K ﹤0.01% 12159
2022
Q2 		– Sell
-12
Closed -$23K – 13454
2022
Q1 		$23K Buy
+12
New +$27.6K ﹤0.01% 13209
2021
Q3 		– Sell
-7
Closed -$68K – 14210
2021
Q2 		$68K Sell
7
-5
-42% -$47.8K ﹤0.01% 13181
2021
Q1 		$159K Buy
+12
New +$207K ﹤0.01% 11971

Other funds holding INBS

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors's INBS Position: Q2 2024 in Review

Citadel Advisors sold out of Intelligent Bio Solutions (INBS) in Q2 2024, closing a stake of 1,484 shares — an estimated $62.6K sold.

Citadel Advisors first reported a position in INBS in Q1 2021 and held it in 7 quarters. The position peaked at $159K in Q1 2021. 8 funds tracked by Wall St. Rank hold INBS as of Q2 2024.

  • Citadel Advisors reported no remaining Intelligent Bio Solutions position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 1,484 Intelligent Bio Solutions shares in Q2 2024, an estimated $62.6K.
  • Citadel Advisors first reported a position in Intelligent Bio Solutions in Q1 2021 and held it in 7 quarters.
  • Citadel Advisors's Intelligent Bio Solutions position peaked at $159K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.